Epalinges, Switzerland · Founded 2020 · Privately Held (backing)
Developer of cost-efficient transcriptomics designed to perform biomedical discoveries. Alithea Genomics is based in Epalinges, Switzerland and was founded in 2020. Its last reported valuation was $66.4 million in Mar 2026. It has raised $9.1 million.
Last reported valuation
$66.4M
Oct 2026
Priced at
—
Total raised
$9.1M
Last round
—
Cap table — not yet on record
Alithea Genomics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Alithea Genomics with a free account
·Watch Alithea Genomics: the Monday email on marks, rounds and moves
